en · de · es · fr · pt
peptide-index.peptides6088.com › Info › Background And Clinical Development — Field Notes

Background And Clinical Development — Field Notes

By Editorial Desk · published 2026-03-29 · last reviewed 2026-05-11 · Info

The short version of GHRH 类似物 fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-05-11. Anything still debated is marked as such rather than presented as settled.

Background and Clinical Development

Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.

A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.

Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.

tesamorelin 背景与作用机制

tesamorelin 是一种人工合成的四十四肽,序列与内源性生长激素释放激素(GHRH)的 1-44 片段一致,区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割,从而延长分子在循环中的存留时间。作为肽类分子,它难以经胃肠道吸收,文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物,以区别于生长激素本身。

作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶,升高细胞内 cAMP,再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点,生长激素仍以脉冲方式分泌,而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生,构成完整的生长激素轴响应。

Tesamorelin at a glance

PropertyValueNotes
Molecular weightApproximately 5,136 DaBased on the 44-amino-acid peptide backbone and N-terminal modification.
AppearanceWhite to off-white lyophilized powderUsually supplied in single-use vials for reconstitution.
SolubilityFreely soluble in water; slightly soluble in some organic solventsPeptide nature supports aqueous reconstitution.
Typical storage2–8 °C, protected from lightRefrigeration reduces degradation; avoid freezing unless specified.
Common analytical methodReverse-phase high-performance liquid chromatographyUsed for identity, purity, and quantification.
SynonymsTesamorelin, TH9507, GHRH(1-44) analogGeneric descriptors; avoid proprietary names.

Background and Clinical Profile

Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.

After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.

Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.

Related pages on this site

Reference notes

=== Anti-mutagenic === In one study, bemethyl was shown to prevent the mutagenic effect of white asbestos in mice and in cultured human whole blood. A study using mice showed bemethyl to reduce mutation induced by certain mutagenic drugs. Another study using cells from human donors showed Bemethyl to be anticlastogenic (able to minimize chromosome breakages).

Hemoglobin acts to transport oxygen which the body receives to all body tissue via blood vessels. Over time, when red blood cells need to be replenished, the hemoglobin is broken down in the spleen; it breaks down into two parts: heme group consisting of iron and bile, and protein fraction. While protein and iron are utilized to renew red blood cells, pigments that make up the red color in blood are deposited into the bile to form bilirubin. Jaundice leads to raised bilirubin levels that in turn negatively remove elastin-rich tissues. Jaundice may be noticeable in the sclera of the eyes at levels of about 2 to 3 mg/dl (34 to 51 μmol/L), and in the skin at higher levels. Jaundice is classified, depending upon whether the bilirubin is free or conjugated to glucuronic acid, into conjugated jaundice or unconjugated jaundice.

Two main commercial implementations of this technology exist: • Syft Technologies Christchurch, New Zealand) offers SIFT-MS instruments (e.g., Voice series), which are the most widely recognized and have popularized the technique for real-time trace gas analysis. • Young In ACE (South Korea) provides the ACE 1100 IMR-MS (Ion Molecule Reaction Mass Spectrometer), developed based on SIFT technology for real-time qualitative and quantitative analysis of volatile organic compounds (VOCs). These instruments enable direct, chromatography-free analysis with soft chemical ionization using reagent ions such as H₃O⁺, NO⁺, and O₂⁺. The SIFT technique, which is the basis of SIFT-MS, was conceived and developed in the 1970s at the University of Birmingham, England, by Nigel Adams and David Smith.

Sources: en.wikipedia.org

Notes from published material

Mild, Unconjugated Hyperbilirubinemia: Total serum bilirubin levels are mildly elevated, typically remaining below 6 mg/dL (102 μmol/L), with a predominance of the unconjugated (indirect) fraction. Normal Liver Function Tests: Liver enzymes, including alanine aminotransferase (ALT) and aspartate aminotransferase (AST), are within normal ranges, indicating no underlying liver disease. Absence of Hemolysis: No evidence of increased red blood cell breakdown, as indicated by normal hemoglobin levels and reticulocyte counts. Intermittent Nature of Symptoms: Episodes of jaundice that may be triggered by factors such as fasting, illness, stress, or exertion, with no other associated symptoms. The level of total bilirubin is often further increased if the blood sample is taken after fasting for two days, and a fast can, therefore, be useful diagnostically. A further conceptual step that is rarely necessary or appropriate is to give a low dose of phenobarbital: the bilirubin will decrease substantially. Exclusion of Other Liver Disorders: No clinical or laboratory evidence of other liver diseases; imaging studies and serologic tests for hepatitis are negative. Genetic Testing: Identification of mutations in the UGT1A1 gene can confirm the diagnosis of Gilbert syndrome. While not routinely required, genetic testing may be considered in cases where the diagnosis is uncertain or to provide reassurance to patients.

Photosynthesis is the synthesis of carbohydrates from sunlight and carbon dioxide (CO2). In plants, cyanobacteria and algae, oxygenic photosynthesis splits water, with oxygen produced as a waste product. This process uses the ATP and NADPH produced by the photosynthetic reaction centres, as described above, to convert CO2 into glycerate 3-phosphate, which can then be converted into glucose. This carbon-fixation reaction is carried out by the enzyme RuBisCO as part of the Calvin–Benson cycle. Three types of photosynthesis occur in plants, C3 carbon fixation, C4 carbon fixation and CAM photosynthesis. These differ by the route that carbon dioxide takes to the Calvin cycle, with C3 plants fixing CO2 directly, while C4 and CAM photosynthesis incorporate the CO2 into other compounds first, as adaptations to deal with intense sunlight and dry conditions. In photosynthetic prokaryotes the mechanisms of carbon fixation are more diverse. Here, carbon dioxide can be fixed by the Calvin–Benson cycle, a reversed citric acid cycle, or the carboxylation of acetyl-CoA. Prokaryotic chemoautotrophs also fix CO2 through the Calvin–Benson cycle, but use energy from inorganic compounds to drive the reaction.

Both the Greek and Roman civilizations practiced ivory carving to make large quantities of high-value works of art, precious religious objects, and decorative boxes for costly objects. Ivory was often used to form the white of the eyes of statues. There is some evidence of either whale or walrus ivory used by the ancient Irish. Solinus, a Roman writer in the 3rd century claimed that the Celtic peoples in Ireland would decorate their sword-hilts with the 'teeth of beasts that swim in the sea'. Adomnan of Iona wrote a story about St Columba giving a sword decorated with carved ivory as a gift that a penitent would bring to his master so he could redeem himself from slavery. The Syrian and North African elephant populations were reduced to extinction, probably due to the demand for ivory in the Classical world. The Chinese have long valued ivory for both art and utilitarian objects. Early reference to the Chinese export of ivory is recorded after the Chinese explorer Zhang Qian ventured to the west to form alliances to enable the eventual free movement of Chinese goods to the west; as early as the first century BC, ivory was moved along the Northern Silk Road for consumption by western nations. Southeast Asian kingdoms included tusks of the Indian elephant in their annual tribute caravans to China. Chinese craftsmen carved ivory to make everything from images of deities to the pipe stems and end pieces of opium pipes.

Sources: en.wikipedia.org

Frequently asked questions

What is tesamorelin?

It is a synthetic peptide analog of human growth hormone-releasing hormone. It is used clinically to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It works by stimulating pituitary growth hormone release.

Which patient group was studied in pivotal trials?

Pivotal trials enrolled adults with HIV and excess visceral abdominal fat, often in the context of antiretroviral therapy. Participants were assessed mainly by computed tomography for visceral adipose tissue. The approved indication remains specific to that population.

What remains uncertain about its long-term effects?

Long-term effects on cardiovascular events, mortality, and sustained fat distribution are not well established. Most trials measured changes over months rather than years. Open questions also include whether benefits persist after treatment stops.

tesamorelin 与生长激素有什么区别?

tesamorelin 属 GHRH 类似物,作用于垂体受体以促进内源生长激素释放;生长激素本身是直接补充的外源激素。两者在给药逻辑、作用位点和反馈调控路径上并不相同。

Network